ArisGlobal
ArisGlobal provides a cloud-based drug development platform, LifeSphere, which enhances pharmacovigilance, clinical trials management, regulatory compliance, and medical affairs with AI technologies.
Services
ArisGlobal offers comprehensive cloud-based services centered around its drug development platform named LifeSphere. The platform provides support for crucial industry operations such as pharmacovigilance, clinical trials management, regulatory compliance, and medical affairs. The suite includes functionalities for multivigilance, intake and triage, reporting and analytics, signal and risk management, and regulatory information management. These services are designed to optimize the workflow in drug development and ensure stringent compliance with industry regulations.
Products
The primary product of ArisGlobal is the LifeSphere platform, a cloud-based end-to-end drug development solution. LifeSphere integrates proprietary cognitive computing engines to enhance its capabilities. Key functionalities of the platform include multivigilance, intake and triage, robust reporting and analytics, signal and risk management, and regulatory information management. The platform employs AI-powered dynamic data extraction and advanced large language model (LLM)-based narrative generation to achieve significant efficiency gains and accuracy in data handling.
Sector
ArisGlobal operates within the life sciences and pharmaceutical sector, specifically focusing on drug development and regulatory compliance. By providing tools for pharmacovigilance, clinical trials management, and medical affairs, ArisGlobal aids biopharma companies in developing and delivering new drugs efficiently and safely. The company's involvement in this space includes leveraging innovative AI technologies to meet the dynamic needs of the life sciences industry.
Global Presence
ArisGlobal serves a worldwide clientele, including 80% of the top 50 biopharma companies. The company is headquartered in the United States but maintains a significant international presence with regional offices in Europe, India, Japan, and China. This global footprint allows ArisGlobal to cater to a diverse set of clients and support different regulatory environments across the world.
GenAI Council for Life Sciences
ArisGlobal hosts the GenAI Council for Life Sciences, an initiative focusing on the adoption and integration of generative AI technologies within the life sciences industry. This council aims to advance the use of AI in drug development processes, optimizing tasks such as data extraction and narrative generation, thereby improving the efficiency and accuracy of data handling in the life sciences sector.